Determination of Malondialdehyde (MDA) and Some Antioxidant Activities in Rheumatoid arthritis Patients
DOI:
https://doi.org/10.36329/jkcm/2023/v2.i10.12258Keywords:
inflammation, rheumatoid arthritisAbstract
Background: Muscle weakness is a common comorbidity of several severe diseases which results in a reduced independence and quality of life and for the afflicted patients. Patients with rheumatoid arthritis (RA), a disease characterized by a chronic inflammation of the joints, commonly report of muscle weakness as a complication. Muscle weakness is the result of reduced muscle size and intramuscular impairments (i.e., intrinsic muscle dysfunction).
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Elham Abdulqadir Abdulrahman1, Halit Demir2, Bakhtyar Kamal Aziz3
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
How to Cite
